News
Medical Device Network on MSN1d
HeartBeam strengthens IP with US patents for cardiac monitoringHeartBeam has secured two new US patents, strengthening its intellectual property (IP) portfolio in cardiac monitoring ...
Medical Device Network on MSN7d
HeartBeam’s ECG technology shows promise in study for arrhythmia diagnosisHeartBeam rolled out an application for its 12-lead ECG synthesis software to the FDA, based on the data from the study.
AliveCor announced today that it launched its most advanced personal ECG system, the AI-powered KardiaMobile 6L Max.
HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology ...
News Medical on MSN8d
AI-ECG tools can help clinicians identify heart issues early in women planning to have childrenEvery year, some mothers die after giving birth due to heart problems, and many of these deaths could be prevented. The ...
Data showed a 93.4% overall diagnostic agreement, indicating that HeartBeam’s synthesized 12-lead ECG can support diagnosis of arrhythmias in a manner consistent with standard 12-lead ECGs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback